Indicator 3.b.1 - Proportion of the target population covered by all vaccines included in their national programme
Goal 3 - Ensure healthy lives and promote well-being for all at all ages
Target 3.b - Support the research and development of vaccines and medicines for the communicable and non‑communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all
Unit %
Short Title
Weightage 5

Year Disaggregation Source Target Value Status Value/Description
2017-18 Total BDHS 85.6000
2017-18 Total DGHS, HSD 86.0000
2017-18 Total BDHS, NIPORT, MEFWD 85.6000
2017-18 Total EPI Coverage Evaluation Survey, DGHS, HSD 86.0000
2019 Total EPI Coverage Evaluation Survey, DGHS, HSD 83.9000
2016 ≤12 months old children DGHS, HSD 82.3000
2016 ≤23 months old children DGHS, HSD 86.8000
2016 ≤12 months old children EPI Coverage Evaluation Survey, DGHS, HSD 82.3000
2016 ≤23 months old children EPI Coverage Evaluation Survey, DGHS, HSD 86.8000
2014 Total BDHS 78.0000